COVID-19 & Parkinson’s Disease
How is coronavirus (COVID-19) related to Parkinson’s? A new review paper titled INFLUENCE OF NOVEL
May 14, 2021
- 951 NW 13th Street, Bldg. 5-E, Boca Raton, FL 33486
Menu
The Challenge of OFF Episodes in Parkinson Disease
An Expert’s Perspective on the Diagnosis and Management of Parkinson’s Disease Psychosis
Treatment options for Parkinson’s disease psychosis
Dr. Stuart Isaacson, Constipation and PD
Stuart Isaacson, MD: The Essential Tremor Treatment Landscape
Stuart Isaacson, MD: Patient Perspective On Essential Tremor Treatment
Continuous Dopaminergic Stimulation – Dr. Stuart Isaacson
OFF Episodes in Parkinson’s Disease
Baseline Dyskinesia Linked to Adverse Event Dyskinesia While on Istradefylline
Management of Sialorrhea in Parkinson Disease
Role of Levodopa in Managing Parkinson Disease
2022 ET Virtual Education Conference Session, Diagnostic and Treatment Options for ET
Scratch-and-sniff test for Parkinson’s disease
Apomorphine Infusion Devices to Manage OFF Episodes in PD
Shared Decision-Making In Parkinson Disease Care
Managing Motor Complications in PD: Evaluating the Role of On-Demand Therapies for “Off” Episodes
Levodopa Inhalation Powder for Parkinson’s Disease
Behind The Mystery: Neurogenic Orthostatic Hypotension (nOH)
The efficacy and safety of SEP-363856 for Parkinson’s disease psychosis
Personalized Care Plans for Patients With Parkinson Disease
Parkinson’s Disease: Evaluating Patients for OFF Episodes
Dose Escalation of Botulinum Toxic Injectables
Expected and Unexpected OFF Episodes in Parkinson’s Disease
Parkinson’s Disease: Advice for Community Neurologists
Effective Symptom Control in Parkinson Disease
Parkinson’s Disease: Why do OFF Episodes Occur?
OFF Episodes in Parkinson’s Disease: Terminology and Patient Experience
Sublingual Apomorphine for Parkinson’s Disease
Impact of Parkinson’s Disease OFF Episodes on Quality of Life
Motor and Non-Motor Symptoms in Parkinson’s Disease
Effective Symptom Control in Parkinson Disease
Future Outlook for Parkinson’s Disease
Current Treatment Paradigm for Management of OFF Episodes
Pharmacological Basis of OFF Episodes in Parkinson’s Disease
Manifestation of OFF Episodes and Impact on Quality of Life in Patients with Parkinson’s Disease
How is coronavirus (COVID-19) related to Parkinson’s? A new review paper titled INFLUENCE OF NOVEL
New Drug, SEP‑363856, Shows Promise in Helping with Parkinson’s Disease Psychosis Our Director, Dr. Stuart
Volunteering for Parkinson’s Research: What to Know and Expect In this podcast interview, Dr. De
Can new drug classes and formulations help reduce breakthrough Parkinson’s activity? Dr. Stuart Isaacson was
The event was held on December 19, 2020 and was free to all online. A
What Choices Do I Have?
You are at no obligation to use this website or sign-up for any clinical research studies. If you do not want to participate, you should not provide any information or register as a member of a study.
How Is Information Collected About You Used?
We may use information we collect about you to:
• Respond to your inquiries via the Contact Us page
• Send you follow-up email announcements and reminders if you Opt-in
Do We Share Your Information with Anyone?
No, we will not disclose any Personal Information about you. We do not make your Personal Information available to third parties for their marketing purposes.
How Do We Secure and Retain Your Information?
We have strict technical, physical, and administrative safeguards to protect the Personal Information that we collect.
Have a Question? Contact Us
Please reach out to us via the Contact Us pages if you have any questions about this Privacy Policy.